Kratom is a plant with psychoactive properties that, when taken at high doses, can produce effects similar to opioids. A new study published in Addiction has found that kratom use – measured as kratom exposures reported to US poison centers – and cases of severe medical outcomes linked to kratom use have surged in the US over the past decade.
The study found that kratom exposures reported to America’s Poison Centers increased from 19 cases in 2010 to 1,242 cases in 2023, a more than a 65-fold (6,500%) increase.
Kratom exposures that included severe outcomes increased from zero cases in 2010 (2012 was the first year in which a severe outcome was reported) to 158 cases in 2023. The authors of the study defined a severe medical outcome as one entailing life-threatening effects, significant residual disability, or death.
US states with kratom bans consistently showed lower rates of exposure, severe outcomes, and healthcare use compared with states using consumer‑protection approaches or no regulation.
Senior author Dr. Ryan Feldman, of the Medical College of Wisconsin, comments: “Kratom is not scheduled under the US Controlled Substances Act or approved for medical use by the FDA, which leaves US states to set their own regulations. Or not: several US states do not regulate kratom at all, and they consistently had worse outcomes in this study than states that banned kratom use.
“Evidence shows kratom can cause serious health effects like seizures, irregular heart rhythms, liver damage, and breathing problems. Nearly one in seven cases reported to a poison center with a single-substance kratom exposure were admitted to a hospital, and one in 16 were admitted to a critical care unit. If kratom is used in combination with other drugs, as it often is, kratom’s tendency to interfere with metabolic pathways can heighten the risks of the accompanying drugs.
“As kratom use rises, and concerns over kratom and its risks increase, legislatures across the country are debating the best ways to regulate its use. Ongoing policy debates reflect limited high‑quality evidence, highlighting the need for more rigorous, unbiased research to guide legislation. As our research here shows, the kratom problem is not going away anytime soon.”
-- Ends –
For editors:
This paper is available to read on the Wiley Online Library for one month from the embargo date ( https://onlinelibrary.wiley.com/doi/10.1111/add.70416 ) or you may request an early copy from Jean O’Reilly, Editorial Manager, Addiction , jean@addictionjournal.org .
To speak with senior author Dr Ryan Feldman, please contact the Medical College of Wisconsin by email at media@mcw.edu .
Full citation for article: Comstock G, Gulotta AP, Rein LE, and Feldman R. Association Between State-Level Kratom Regulations and Poison Center-Reported Severe Medical Outcomes and Healthcare Use: A United States National Analysis. Addiction . 2026. DOI: 10.1111/add.70416
Primary funding: No funding was provided for this research.
Declaration of interests: The authors report no conflicts of interest to disclose.
Addiction is a monthly international scientific journal publishing peer-reviewed research reports on alcohol, substances, tobacco, gambling, editorials, and other debate pieces. Owned by the Society for the Study of Addiction, it has been in continuous publication since 1884.
Addiction
Observational study
People
Association Between State-Level Kratom Regulations and Poison Center-Reported Severe Medical Outcomes and Healthcare Use: A United States National Analysis
22-Apr-2026
The authors report no conflicts of interest to disclose.